# ClinicalTrials.gov record NCT01097044

> PeptideScanner retained ClinicalTrials.gov record NCT01097044 at 2026-07-30T20:44:36.694Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was afamelanotide.

- Evidence object: `story:clinicaltrials-gov-nct01097044-afamelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-10-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01097044-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01097044-afamelanotide-v1.json
- Content SHA-256: `6bb57885cb30b2f398dfb01357c30d2a21e0e943af5baa16ec3fc9cce23d6536`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01097044 ([`ctg-observation-nct01097044-2019-10-28-043f9a0b1758`](#source-ctg-observation-nct01097044-2019-10-28-043f9a0b1758))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01097044 at 2026-07-30T20:44:36.694Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct01097044-2019-10-28-043f9a0b1758`](#source-ctg-observation-nct01097044-2019-10-28-043f9a0b1758))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01097044 at 2026-07-30T20:44:36.694Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct01097044-2019-10-28-043f9a0b1758`](#source-ctg-observation-nct01097044-2019-10-28-043f9a0b1758))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01097044-2019-10-28-043f9a0b1758`](#source-ctg-observation-nct01097044-2019-10-28-043f9a0b1758))

## Sources

<a id="source-ctg-observation-nct01097044-2019-10-28-043f9a0b1758"></a>
- **ClinicalTrials.gov record NCT01097044 · retained source version 2019-10-28:043f9a0b175837d08e4807fd59c06a6bae466562434dadc7cca25ac361801015** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01097044) (`ctg-observation-nct01097044-2019-10-28-043f9a0b1758`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01097044." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01097044-afamelanotide-v1.json SHA-256: 6bb57885cb30b2f398dfb01357c30d2a21e0e943af5baa16ec3fc9cce23d6536.